Article
MDM2 SNP309 polymorphism and colorectal cancer risk: a meta-analysis.
DNA and cell biology - 1 Mar 2012
Cao Xiangming, Zhang Tingrong, Zhao Zhen, Zhao Tao
Abstract excerpt
MDM2 is a phosphoprotein that interacts with p53 and inhibits its activity. Recently, a T to G substitution (SNP309) in the promoter of MDM2 was identified and associated with increased MDM2 expression and a significantly earlier age of onset of several tumors, including colorectal cancer. Several studies evaluated the association between SNP309 and colorectal cancer risk in diverse populations. However, the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
